Literature DB >> 9620397

Cloning and expression of the 44-kilodalton major outer membrane protein gene of the human granulocytic ehrlichiosis agent and application of the recombinant protein to serodiagnosis.

N Zhi1, N Ohashi, Y Rikihisa, H W Horowitz, G P Wormser, K Hechemy.   

Abstract

A 44-kDa major outer membrane protein of the human granulocytic ehrlichiosis (HGE) agent is an immunodominant antigen in human infection. A gene encoding this protein was cloned and sequenced. Southern blot results revealed the existence of multigenes homologous to the P44 gene in the genome of the HGE agent. The recombinant 44-kDa protein (rP44) was expressed by using expression vector pET30a. The reactivity of the affinity-purified rP44 was evaluated by Western immunoblot analysis and dot blot immunoassay. Western immunoblot analysis showed that mouse anti-rP44 serum reacted with 44- to 42-kDa proteins in six different HGE agent strains tested except strain 2, in which three proteins of 42, 40, and 38 kDa were recognized. Eleven HGE patient serum samples, a horse anti-HGE serum, and a horse anti-Ehrlichia equi serum recognized the rP44 protein. This suggests that rP44 is an HGE-E. equi group-specific antigen. Neither human anti-Ehrlichia chaffeensis serum nor rabbit anti-Borrelia burgdorferi serum reacted with rP44. Sera from two patients coinfected with the HGE agent and B. burgdorferi reacted positively with rP44 and the HGE agent. Sera from 20 HGE patients with indirect fluorescent-antibody (IFA) titers ranging from 1:20 to 1:2,560 gave distinct positive reactions in a dot immunoblot assay. There was a positive correlation between the color densities of the dot reactions and the IFA titers when greater than 50 ng of recombinant antigen per dot was used. The use of the affinity-purified rP44 protein as antigen would provide a more specific, consistent, and simpler serodiagnosis for HGE than the use of whole infected cells or purified HGE agents.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620397      PMCID: PMC104897     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  29 in total

1.  Overexpression and surface localization of the Chlamydia trachomatis major outer membrane protein in Escherichia coli.

Authors:  J E Koehler; S Birkelund; R S Stephens
Journal:  Mol Microbiol       Date:  1992-05       Impact factor: 3.501

2.  Human granulocytic ehrlichiosis: a case series from a medical center in New York State.

Authors:  M E Aguero-Rosenfeld; H W Horowitz; G P Wormser; D F McKenna; J Nowakowski; J Muñoz; J S Dumler
Journal:  Ann Intern Med       Date:  1996-12-01       Impact factor: 25.391

3.  False-positive Lyme disease serology in human granulocytic ehrlichiosis.

Authors:  G P Wormser; H W Horowitz; J S Dumler; I Schwartz; M Aguero-Rosenfeld
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321

4.  Serodiagnosis of scrub typhus with antigens immobilized on nitrocellulose sheet.

Authors:  H Urakami; S Yamamoto; T Tsuruhara; N Ohashi; A Tamura
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

5.  Immunodominant major outer membrane proteins of Ehrlichia chaffeensis are encoded by a polymorphic multigene family.

Authors:  N Ohashi; N Zhi; Y Zhang; Y Rikihisa
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

6.  Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease.

Authors:  S M Chen; J S Dumler; J S Bakken; D H Walker
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

7.  Western immunoblot analysis of Ehrlichia chaffeensis, E. canis, or E. ewingii infections in dogs and humans.

Authors:  Y Rikihisa; S A Ewing; J C Fox
Journal:  J Clin Microbiol       Date:  1994-09       Impact factor: 5.948

8.  Direct cultivation of the causative agent of human granulocytic ehrlichiosis.

Authors:  J L Goodman; C Nelson; B Vitale; J E Madigan; J S Dumler; T J Kurtti; U G Munderloh
Journal:  N Engl J Med       Date:  1996-01-25       Impact factor: 91.245

9.  Antigenic, morphologic, and molecular characterization of new Ehrlichia risticii isolates.

Authors:  W Chaichanasiriwithaya; Y Rikihisa; S Yamamoto; S Reed; T B Crawford; L E Perryman; G H Palmer
Journal:  J Clin Microbiol       Date:  1994-12       Impact factor: 5.948

10.  The immunoprotective Anaplasma marginale major surface protein 2 is encoded by a polymorphic multigene family.

Authors:  G H Palmer; G Eid; A F Barbet; T C McGuire; T F McElwain
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

View more
  50 in total

1.  Serology of culture-confirmed cases of human granulocytic ehrlichiosis.

Authors:  M E Aguero-Rosenfeld; F Kalantarpour; M Baluch; H W Horowitz; D F McKenna; J T Raffalli; T c Hsieh; J Wu; J S Dumler; G P Wormser
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Anaplasma phagocytophilum modulates gp91phox gene expression through altered interferon regulatory factor 1 and PU.1 levels and binding of CCAAT displacement protein.

Authors:  Venetta Thomas; Swapna Samanta; Caiyun Wu; Nancy Berliner; Erol Fikrig
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Cloning of the major outer membrane protein expression locus in Anaplasma platys and seroreactivity of a species-specific antigen.

Authors:  Tzung-Huei Lai; Nelson G Orellana; Yumi Yuasa; Yasuko Rikihisa
Journal:  J Bacteriol       Date:  2011-04-15       Impact factor: 3.490

4.  Characterization of monoclonal antibodies to the 44-kilodalton major outer membrane protein of the human granulocytic ehrlichiosis agent.

Authors:  H Y Kim; Y Rikihisa
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

5.  Persistence of Anaplasma ovis infection and conservation of the msp-2 and msp-3 multigene families within the genus Anaplasma.

Authors:  G H Palmer; J R Abbott; D M French; T F McElwain
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

6.  Comparison of PCR assays for detection of the agent of human granulocytic ehrlichiosis, Anaplasma phagocytophilum.

Authors:  Robert F Massung; Kimetha G Slater
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

7.  Cloning and characterization of multigenes encoding the immunodominant 30-kilodalton major outer membrane proteins of Ehrlichia canis and application of the recombinant protein for serodiagnosis.

Authors:  N Ohashi; A Unver; N Zhi; Y Rikihisa
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

8.  Multiplex real-time PCR for detection of anaplasma phagocytophilum and Borrelia burgdorferi.

Authors:  Joshua W Courtney; Leah M Kostelnik; Nordin S Zeidner; Robert F Massung
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

9.  Anaplasma phagocytophilum Ats-1 is imported into host cell mitochondria and interferes with apoptosis induction.

Authors:  Hua Niu; Vera Kozjak-Pavlovic; Thomas Rudel; Yasuko Rikihisa
Journal:  PLoS Pathog       Date:  2010-02-19       Impact factor: 6.823

10.  Analysis of sequences and loci of p44 homologs expressed by Anaplasma phagocytophila in acutely infected patients.

Authors:  Quan Lin; Ning Zhi; Norio Ohashi; Harold W Horowitz; Maria E Aguero-Rosenfeld; John Raffalli; Gary P Wormser; Yasuko Rikihisa
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.